Q32 Bio Inc. (QTTB) stock
QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.53−0.10 (-1.16%)
Close on Nov 18, 2026Market cap $253.93MP/E –Yield –
Q32 Bio revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Q32 Bio's revenue for the twelve months ending Dec 31, 2024 was $0. For fiscal 2025 it was $53.74M. The highest annual figure on record is $53.74M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.74M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | -$6.65M | -307.3% |
| FY2022 | Dec 31, 2022 | $3.21M | -90.6% |
| FY2021 | Dec 31, 2021 | $33.97M | +1157.3% |
| FY2020 | Dec 31, 2020 | $2.70M | +62.2% |
| FY2019 | Dec 31, 2019 | $1.67M | -68.7% |
| FY2018 | Dec 31, 2018 | $5.32M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | $0 | – |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $0 | -100.0% |
| Q1 FY2024 | Mar 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.86M | +131.8% |
| Q2 FY2023 | Jun 30, 2023 | $3.21M | +299.6% |
| Q1 FY2023 | Mar 31, 2023 | $2.95M | +267.5% |
| Q4 FY2022 | Dec 31, 2022 | $802.00K | 0.0% |
| Q3 FY2022 | Sep 30, 2022 | $802.00K | -52.2% |
| Q2 FY2022 | Jun 30, 2022 | $802.00K | -63.3% |
| Q1 FY2022 | Mar 31, 2022 | $802.00K | -97.3% |
| Q4 FY2021 | Dec 31, 2021 | $802.00K | -18.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.68M | +195.8% |
| Q2 FY2021 | Jun 30, 2021 | $2.19M | +285.7% |
| Q1 FY2021 | Mar 31, 2021 | $29.31M | +4883.8% |
| Q4 FY2020 | Dec 31, 2020 | $980.00K | +74.1% |
| Q3 FY2020 | Sep 30, 2020 | $567.00K | +28.6% |
| Q2 FY2020 | Jun 30, 2020 | $567.00K | +44.6% |
| Q1 FY2020 | Mar 31, 2020 | $588.00K | +117.8% |
| Q4 FY2019 | Dec 31, 2019 | $563.00K | -52.9% |
| Q3 FY2019 | Sep 30, 2019 | $441.00K | -72.5% |
| Q2 FY2019 | Jun 30, 2019 | $392.00K | -71.9% |
| Q1 FY2019 | Mar 31, 2019 | $270.00K | -76.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.20M | – |
| Q3 FY2018 | Sep 30, 2018 | $1.60M | – |
| Q2 FY2018 | Jun 30, 2018 | $1.40M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.13M | – |
See a number that looks wrong?